Skip to main content

Table 1 Detailed participants for each outcomes including their quality of evidence

From: Equiosmolar doses of hypertonic saline versus mannitol for brain relaxation in patients undergoing elective craniotomies: an updated systematic review and meta-analysis

Outcomes

Number of participants (studies)

Certainty of the evidence (GRADE)

Relative effect (95% CI)

Anticipated absolute effects

Risk with mannitol

Risk difference with hypertonic saline

Brain Relaxation*

745

OR 1.84

67 per 100

12 more per 100

(10 RCTs)

Moderatea

(1.31 to 2.59)

(6 more to 17 more)

Total urine output*

615

SMD 0.75 SD lower

(7 RCTs)

Moderateb

(0.92 lower to 0.22 lower)

Serum osmolality

164

The mean serum osmolality was 296.6 mOsm/L

MD 1.97 mOsm/L higher

(3 RCTs)

Very lowb,c

(3.05 lower to 7 higher)

Arterial sodium*

328

The mean arterial sodium was 132 mmol/L

MD 12.69 mmol/L higher

(3 RCTs)

Lowb,c

(10.85 higher to 14.53 higher)

Serum sodium*

253

The mean serum sodium was 138 mmol/L

MD 4.5 mmol/L higher

(5 RCTs)

Moderatec

(3.65 higher to 5.35 higher)

Fluid input*

576

SMD 0.56 SD lower

(6 RCTs)

Moderateb

(0.98 lower to 0.15 lower)

Max MAP

139

The mean max MAP was 84.7 mmHg

MD 1.83 mmHg higher

(3 RCTs)

Very lowb,c

(1.54 lower to 5.2 higher)

Max CVP

263

The mean max CVP was 8.6 mmHg

MD 0.56 mmHg higher

(RCTs)

Lowc,d

(0.68 lower to 1.8 higher)

  1. CVP: central venous pressure; MAP: mean arterial pressure; MD: mean difference; SMD: standardised mean difference; SD: standard deviation; CI: confidence interval; OR: odd ratio
  2. *Statistically significant, P value < 0.05
  3. aMultiple unclear risk of bias on random sequence generation
  4. bThere is a significant level of heterogeneity among studies
  5. cSmall sample size
  6. dThere is a mild level of heterogeneity among studies